Skip to main content
NANN 2023 Annual Conference Main banner
Final Program


2023 Brochure
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Coffee Service
Coffee Service
Handout Provided
Handout Provided
Food & Beverage
Food & Beverage
Industry Session
Industry Session
In-person ONLY
In-person ONLY
Recording Coming Soon!
Recording Coming Soon!
Members ONLY
Members ONLY
Networking Session
Networking Session
On-demand Session
On-demand Session
Separate Registration Required
Separate Registration Required
Video

General Session

New Insights Surrounding Red Blood Cell Products and Hemoglobin as a Transfusion Trigger in Preterm Infants (GS2)

Wednesday, September 27, 2023
9:00 AM - 10:00 AM PT
Location: Platinum Ballroom 5-6
Earn 1 Contact Hour(s)
Handout Provided On-demand Session
RNC-NIC: 2
NNP-BC: 2
RNC-LRN: 3
C-ELBW (code 7)
Pharmacology Credits: 0
The audience will learn about the most recent advances in translational and clinical research surrounding red blood cell transfusion in preterm infants. Participants will be better prepared to explain the limitations of using hemoglobin as a transfusion trigger. Finally, neonatal nurses will gain a new perspective on RBCs as a biologic and not a pharmaceutical product, explaining the variability around RBCs transfusion outcomes in preterm infants.

Learning Outcome(s):

At the conclusion of this presentation, the learner will be able to:
  1. Examine donor RBC variability, irradiation, and storage on recipient tissue bed oxygenation, morbidity, and mortality.
  2. Discuss limitations of hemoglobin as a surrogate for tissue oxygenation and trigger for RBC transfusion.